Ascentage Pharma Group International Unsponsored ADRAscentage Pharma Group International Unsponsored ADRAscentage Pharma Group International Unsponsored ADR

Ascentage Pharma Group International Unsponsored ADR

No trades
See on Supercharts
Next report date
Report period
EPS estimate
Revenue estimate
Market capitalization
‪3.81 B‬USD
−2.01USD
‪−56.34 M‬USD
‪136.26 M‬USD
Beta (1Y)
0.29

About Ascentage Pharma Group International


CEO
Da Jan Yang
Headquarters
Suzhou
Founded
2009
ISIN
US04390B1052
FIGI
BBG01RJXM9C9
Ascentage Pharma Group International Co., Ltd. is a clinical-stage biotechnology company. It engages in the development of novel therapies for cancers, hepatitis B virus, or HBV, and age-related diseases. The company was founded by Da Jun Yang, Wang Shao Meng and Ming Guo in May 2009 and is headquartered in Suzhou, China.

Check out other big names from the same industry as AAPG.
Performance
Revenue to profit conversion
Debt level and coverage
Earnings
Next:
Summarizing what the indicators are suggesting.
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
An aggregate view of professional's ratings.
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy